Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Cristina Brambilla's publication output changed over time?
ScholarIQpublication output · 1975–2025
Output grew0% over the shown period — from 1 works in 1975 to 1 in 2025.
1
2
1
1
2
1
1
1
1
197519761985199019951997199820232025
What are the most-cited papers on Cristina Brambilla?
ScholarIQmost cited works
Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer
Gianni Bonadonna, Ercole Brusamolino, Pinuccia Valagussa, Anna Rossi, Luisa Brugnatelli, Cristina Brambilla, Mario De Lena, Gabriele Tancini, Emilio Bajetta, R Musumeci, Umberto Veronesi
New England Journal of Medicine. 19761,334 Citations
Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil in Node-Positive Breast Cancer — The Results of 20 Years of Follow-up
G. Bonadonna, Pinuccia Valagussa, Angela Moliterni, Milvia Zambetti, Cristina Brambilla
New England Journal of Medicine. 19951,055 Citations
Primary Chemotherapy To Avoid Mastectomy in Tumors With Diameters of Three Centimeters or More
Giovanni Bonadonna, Umberto Veronesi, Cristina Brambilla, L. Ferrari, Alberto Luini, Marco Greco, Cesare Bartoli, Guillermo Yoldi, R Zucali, Franco Rilke, Salvatore Andreola, Rosella Silvestrini, G. Di Fronzo, Pinuccia Valagussa
JNCI Journal of the National Cancer Institute. 1990613 Citations
Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute.
G. Bonadonna, Pinuccia Valagussa, Cristina Brambilla, L. Ferrari, Angela Moliterni, Monica Terenziani, Milvia Zambetti
Journal of Clinical Oncology. 1998568 Citations
High-Dose Chemotherapy and Autologous Bone Marrow Transplantation Compared with MACOP-B in Aggressive B-Cell Lymphoma
Alessandro M. Gianni, Marco Bregni, Salvatore Siena, Cristina Brambilla, Massimo Di Nicola, Fabrizio Lombardi, Lorenza Gandola, Corrado Tarella, Alessandro Pileri, Fernando Ravagnani, Pinuccia Valagussa, Gianni Bonadonna
New England Journal of Medicine. 1997478 CitationsOPEN ACCESS
Related on ScholarIQ
National Research Council
Institution
Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer
Paper
Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil in Node-Positive Breast Cancer — The Results of 20 Years of Follow-up
Paper
Primary Chemotherapy To Avoid Mastectomy in Tumors With Diameters of Three Centimeters or More
Paper
Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute.
Paper
High-Dose Chemotherapy and Autologous Bone Marrow Transplantation Compared with MACOP-B in Aggressive B-Cell Lymphoma
Paper